Denovo Biopharma Partners With Orygen for Phase 2 Study of Pomaglumetad Methionil in Treating Psychosis February 12, 2026 mental-health ONLY AVAILABLE IN PAID PLANS. Originally reported by psychiatrictimes. Read more Source: https://www.psychiatrictimes.com/view/denovo-biopharma-partners-with-orygen-for-phase-2-study-of-pomaglumetad-methionil-in-treating-psychosis
